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Conclusion: Findings call for urgent pragmatic commitment,
measures andevidence informed strategies and programmes-
planning. Meanwhile efforts towards understanding contextual
trend in epidemiology of emerging infectious and neglected tropi-
cal diseases in eachmember country is needed through operational
research and research in achieving the goal of the London declara-
tion and the Millennium Development Goals.
http://dx.doi.org/10.1016/j.ijid.2014.03.909
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Background: Bioenhancers are agents when combined with an
active drug lead to potentiate the pharmacological effect of the
drug but themselves are not having any therapeutic effect. Recent
development in bioavailability enhancement of drugs by herbal
compounds has produced a new shift in the way of therapeutics.
Bioenhancers improvepermeability and inﬂuencebioavailability of
the drug for therapeutic efﬁcacy which may result into decrease in
dose ensuring therapeutic availability. The major problems associ-
ated with the anti-TB drug therapy include loss of efﬁcacy through
bacterial resistance, side effects, and low patient compliance. In
the cited research work, we have attempted to solve the above
mentioned problems by simultaneous use of both the concepts
of microsphere drug delivery (higher bioavailability) and herbal
bioenhancers (improved bioavailability).
Methods & Materials: Methods: Complex coacervation and
modiﬁed emulsion method.
Material: Isoniazid and rifampicin as a model drug used in TB
therapy. Hydro-alcoholic extracts of Carum carvi and Ocimum sanc-
tum were used as bioenhancer.
Results: The in-vitro drug release of isoniazid and rifampicin
from formulations where bioenhancer extract is used was found
to be about 85-90% in 12hrs. While the same was about 45-50%
in case of formulations where bioenhancers were not used. Other
parameters like percentage bioadhesion, permeability study using
intestinal sac method etc. were also studied.
Conclusion: For microspheres prepared by both complex coac-
ervation and modiﬁed emulsion methos, the particle size was
uniform and found to be less than 130 micron in size; the particle
size may alter on addition of bioenhancer extract to the formu-
lations. The drug encapsulation efﬁciency was found to be in the
range of 43-67% (increased on addition of bioenhancer in the for-
mulations). The percentage bioadhesion of the microsphere where
bioenhancers were used found to increase by 20% as compared to
basal value (upto 67% from 42%). The in- vitro release study by USP
paddle apparatus and the most important results from the in-vitro
release study relates to the very signiﬁcant enhancement in drug
release (45 to 90% for microspheres prepared by modiﬁed emul-
sion method and 47 to 90% complex coacervation method), due to
presence of bioenhancers alone and in combination.
http://dx.doi.org/10.1016/j.ijid.2014.03.910
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Background: Every year more than 24000 deaths are reported
due to severeDengueFever (DF)worldwide. Theexactpathogenetic
mechanismsof severity ofDengue Fever (DF) is still not clear. In this
study we attempted to estimate some biomarkers as risk factors
associated with severity of DF.
Methods & Materials: It was a prospective observational case
control study conducted at AIIMS Hospital. We estimated serum
level of TNF-alpha, IL-6 and sTM among shock and non-shock
patients at the time of 1st visit either as OPD patients or at the
time of admission and followed them up till death, discharge(for
admitted patients) or 14 days (for OPD patients).
Results: The mean age of Dengue shock patients was 28.9±10.8
years and themeanageofnon-shockwas29.2±10.9years.Outof 30
shockpatients 20 (66.7%)weremale andamongnon-shock35(70%)
were male. Mean value of sTM was 15.8±6.4 ng/ml among shock
(case) and 6.4±4.4 ng/ml among non-shock (control) and the dif-
ference was highly statistically signiﬁcant (p<0.001). Higher serum
level of sTM (>15 ng/ml) were found among 21 cases (70%) from
shock(case) group and 3 cases (6%) from non-shock(control) which
was also found to have statistically signiﬁcant (<0.001). About 12
cases (39.9%) from shock and 10 cases (20%) from non-shock were
detected to have elevated TNF-alpha (>100 pg/ml) which was not
found to have statistical signiﬁcant (<0.12). About 11 cases (37.7%)
from shock and 15 cases (30%) from non-shock were found to have
elevated IL-6 (>100 pg/ml) which was also not found to have sta-
tistically signiﬁcant (<0.09). We found 22% incidence (11) of shock
among Dengue Fever (non-shock) during follow up for 14 days. We
found signiﬁcant higher base level of serumsTM (13±4.67) and IL-6
(136±76.4) among these 22% (11) patients those who had normal
blood pressure at the 1st visit but subsequently developed shock
during follow up.
Conclusion: sTM and IL-6 both biomarkers could be useful for
predicting Severe Dengue Fever well in advance before develop-
ment of shock or severe DF.
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